Corrigendum to: Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C

Neuro Oncol. 2023 Mar 14;25(3):615. doi: 10.1093/neuonc/noad026.
No abstract available

Publication types

  • Published Erratum